Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Eli Lilly & Co. (NY: LLY)
52.35 USD  -0.01 (-0.02%)
Official Closing Price  /  Updated: 6:40 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Eli Lilly & Co.
 
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Lilly Declares Third-Quarter 2013 Dividend
June 18, 2013
from PR Newswire
Key to Success, How to Profit: HAL, CLF, LLY and LOW
June 17, 2013
from Marketwired News Releases
New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia
June 17, 2013
Study results presented at ENDO 2013 Annual Meeting Read More
from PR Newswire
Lilly Diabetes, Kris Freeman Kick off Summer with 9th Annual Diabetes Summer Camp Tour
June 17, 2013
New video reveals diabetes struggles, chase for Olympic gold and the spirit of a champion Read More
from PR Newswire
Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimer's Disease
June 13, 2013
Decision does not impact other Lilly Alzheimer's compounds in development Read More
from PR Newswire
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
June 13, 2013
from PR Newswire
Lilly and Incyte Announce Baricitinib Efficacy and Safety Data from the Open-Label, Long-Term Extension of the Phase 2b JADA Study in Patients with Rheumatoid Arthritis
June 13, 2013
- Results from 52-week study presented at EULAR 2013 - Read More
from PR Newswire
Research Study Results Bring Hope for Combating Debilitating Diseases - Research Report on Johnson & Johnson, AbbVie, Lilly, Novartis and GlaxoSmithKline
June 12, 2013
from PR Newswire
Lilly to Highlight Late-Stage Pipeline Molecules at the 73rd American Diabetes Association Scientific Sessions®
June 11, 2013
Company to showcase data for investigational GLP-1 receptor agonist and investigational novel basal insulin analog Read More
from PR Newswire
Boehringer Ingelheim and Eli Lilly and Company Alliance to Feature 34 Presentations on Type 1 and Type 2 Diabetes at the 73rd American Diabetes Association Scientific Sessions®
June 11, 2013
Alliance to feature research data for linagliptin and the investigational compound empagliflozin* Read More
from PR Newswire
Critical Alerts For Amazon.com, Eli Lilly, GNC Holdings, AngloGold Ashanti, and Rosetta Resources Released By InvestorsObserver
June 10, 2013
from PR Newswire
American Diabetes Association and Lilly Announce Creation of Research Awards
June 04, 2013
Research Funding of $1.2 Million Will Focus on Diabetes Care in Older Adults Read More
from Marketwired News Releases
PRONOUNCE Study Does Not Achieve Primary Superiority Endpoint for ALIMTA® (pemetrexed for injection), Similar PFS and OS Results Were Observed Between the Two Drug and the Three Drug Regimens in the T
June 03, 2013
from PR Newswire
New Mobile App Assists Oncologists In Navigating Ever-Evolving Sea Of Cancer Information
May 31, 2013
Lilly Oncology partners with MDLinx to make new research easily accessible Read More
from PR Newswire
Lilly Statement on Indiana Biosciences Research Institute
May 30, 2013
from PR Newswire
Lilly to Present at Goldman Sachs Global Healthcare Conference
May 30, 2013
from PR Newswire
New Data on FORTEO® (teriparatide [rDNA origin] injection) Show Increased Bone Mineral Density in Men with Glucocorticoid-Induced Osteoporosis
May 29, 2013
from PR Newswire
Corgenix Announces Diagnostic Development Agreement with Lilly
May 22, 2013
from Business Wire News Releases
From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients
May 20, 2013
Video shows how those from the medical field bring patient care experience to pharmaceutical career Read More
from PR Newswire
Lilly Oncology to Release New Pipeline Data at ASCO 2013
May 14, 2013
Data from Pipeline Molecules Targeting Key Cancer Pathways to be Presented Read More
from PR Newswire
Lilly Provides Update on CEO Dr. John Lechleiter
May 14, 2013
from PR Newswire
Perfect Trade Setups, How to Play NLY, CHK, WCRX and LLY
May 14, 2013
from Marketwired News Releases
The Straight Truth, Investing in C, LLY, AMZN and FB
May 11, 2013
from Marketwired News Releases
Strategy Behind Our Success, We Get in Early: LLY, COP, GE and EXC
May 10, 2013
from Marketwired News Releases
Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
May 10, 2013
from PR Newswire
The Reason It Trades, What's Moving LLY, MBI, REGN and BMY
May 08, 2013
from Marketwired News Releases
Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
May 06, 2013
Retrospective pooled analyses evaluated linagliptin treatment in American Hispanic/Latino people with type 2 diabetes, as well as in people living with type 2 diabetes for at least 10 years Read More
from PR Newswire
Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
May 06, 2013
from PR Newswire
Lilly Declares Second-Quarter 2013 Dividend
May 06, 2013
from PR Newswire
Critical Alerts For Microsoft, Suncor Energy, Eli Lilly, TRW Automotive, and Embraer Released By InvestorsObserver
May 02, 2013
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
3
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
4
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
5
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland